Literature DB >> 18708123

The LARK/RBM4a protein is highly expressed in cerebellum as compared to cerebrum.

Thorsten Pfuhl1, Alfredo Mamiani, Matthias Dürr, Susanne Welter, Johanna Stieber, Jasmin Ankara, Michael Liss, Thomas Dobner, Andrea Schmitt, Peter Falkai, Elisabeth Kremmer, Volker Jung, Stephanie Barth, Friedrich A Grässer.   

Abstract

The RNA binding motif protein 4 genes RBM4a and RBM4b are located on human chromosome 11q13.2 and encode highly similar proteins of 363 and 359 amino acids, respectively. They contain two RNA recognition motifs (RRMs) and a retroviral-type Zn-finger. RBM4a binds RNA, is involved in alternative splicing and is also a part of the microRNA-processing RISC complex. In particular, RBM4a is involved in exon 10 inclusion of the tau protein. The function of RBM4b is unknown. With new monoclonal antibodies we show that RBM4a is detectable in virtually all tissues and cell lines tested while RBM4b was only found in kidney and liver. Both RBM4a and RBM4b are nuclear phosphoproteins with half-lives of 2.5h and 4.5h, respectively. To our knowledge, this is the first description of RBM4b protein in human tissue. In human brain, expression of RBM4a was strongly up-regulated in cerebellum as compared to forebrain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18708123     DOI: 10.1016/j.neulet.2008.08.017

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Unique ability of pandemic influenza to downregulate the genes involved in neuronal disorders.

Authors:  Esmaeil Ebrahimie; Zahra Nurollah; Mansour Ebrahimi; Farhid Hemmatzadeh; Jagoda Ignjatovic
Journal:  Mol Biol Rep       Date:  2015-08-06       Impact factor: 2.316

2.  Functional pre- mRNA trans-splicing of coactivator CoAA and corepressor RBM4 during stem/progenitor cell differentiation.

Authors:  Yang S Brooks; Guanghu Wang; Zheqiong Yang; Kimberly K Smith; Erhard Bieberich; Lan Ko
Journal:  J Biol Chem       Date:  2009-05-05       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.